Literature DB >> 17516692

Impaired rehabilitation secondary to muscle weakness induced by meropenem.

Leon Margolin1.   

Abstract

Entities:  

Year:  2004        PMID： 17516692     DOI： 10.2165/00044011-200424010-00008

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  3 in total

1.  Laboratory abnormalities in patients with bacterial pneumonia.

Authors:  R T Sankaran; J Mattana; S Pollack; P Bhat; T Ahuja; A Patel; P C Singhal
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

2.  Hypokalemia associated with ticarcillin-clavulanic acid.

Authors:  R Titanji; A Trofa
Journal:  Md Med J       Date:  1993-10

3.  Frequency and significance of electrolyte abnormalities in pneumonia.

Authors:  S Singhi; A Dhawan
Journal:  Indian Pediatr       Date:  1992-06       Impact factor: 1.411
  3 in total
  5 in total

1.  Meropenem-induced hypokalemia and metabolic alkalosis.

Authors:  Syed Ahmed Zaki; Preeti Shanbag
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

2.  Rhabdomyolysis as Potential Late Complication Associated with COVID-19.

Authors:  Kok Hoe Chan; Jihad Slim
Journal:  Emerg Infect Dis       Date:  2020-07-02       Impact factor: 6.883

3.  Identifying alternative antibiotics that elute from calcium sulfate beads for treatment of orthopedic infections.

Authors:  Ashley E Levack; Kathleen Turajane; Daniel A Driscoll; Xu Yang; Andy O Miller; Mathias P Bostrom; David S Wellman; Alberto V Carli
Journal:  J Orthop Res       Date:  2021-07-12       Impact factor: 3.102

4.  Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Authors:  Chengwen Teng; Courtney Baus; James P Wilson; Christopher R Frei
Journal:  Int J Med Sci       Date:  2019-10-15       Impact factor: 3.738

5.  Polymyxin B-induced rhabdomyolysis: A case report.

Authors:  Ming Ni; Xiangdong Meng; Limin Wang; Yanan Zhao; Min Yu; Sheng Shi
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.